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Background: The fruit of Hylocereus polyrhizus, also known as red pitaya, and buah naga in Malay, is one of the
tropical fruits of the cactus family, Cactaceae. Red pitaya has been shown to protect aorta from oxidative damage
and improve lipid profiles in hypercholesterolemic rats probably due to phytochemicals content including
phenolics and flavonoids. The aim of this study was to investigate the changes in cardiac stiffness, hepatic and
renal function in high-carbohydrate, high-fat diet-induced obese rats following supplementation of red pitaya juice.
Methods: Total 48 male Wistar rats were divided into 4 groups: corn-starch group (CS), corn-starch + red pitaya
juice group (CRP), high-carbohydrate, high fat group (HCHF) and high-carbohydrate, high fat + red pitaya juice
(HRP). The intervention with 5% red pitaya juice was started for 8 weeks after 8 weeks initiation of the diet. Heart
function was determined ex vivo with Langendorff hearts while plasma liver enzymes, uric acid and urea were
measured using commercial kits. Total fat mass was determined with Dual-energy X-ray absorptiometry (DXA) scan.
Glucose uptake was measured with Oral Glucose Tolerance Test (OGTT). Liver and cardiac structures were defined
by histology.
Results: Supplementation of red pitaya juice for 8 weeks increased energy intake and abdominal circumference
but no change in body fat and lean mass respectively. Also, there were a trend of uric acid and glucose
normalization for HRP as compared to H-fed rats. Red pitaya juice treatment reduced ALP and ALT but caused
significant increment in AST. Diastolic stiffness of the heart was reduced after supplementation of red pitaya juice in
corn starch fed rats. However, the reduction was not significant in HRP rats in comparison with H rats.
Conclusion: The present study concluded that red pitaya juice may serve as a complimentary therapy for
attenuating some signs of metabolic syndrome.
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Overweight and obesity are dramatically on the rise in re-
cent decades. According to WHO [1], obesity contributed
to double burden of diseases particularly diabetes (44%),
ischemic heart diseases (23%), and certain types of cancer
(7-41%). This is due to the metabolic abnormalities cre-
ated by excessive fat accumulation like abnormalities of* Correspondence: asmah@upm.edu.my
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unless otherwise stated.lipid in the blood, hypertension and impaired glucose
tolerance, among which are the common features of meta-
bolic syndrome [2]. In patients with metabolic syndrome,
insulin resistance results in the impaired insulin activities
in tissues like muscle, liver, kidney and fat leading to
increase oxidative stress, pro-coagulant/anti-fibrinolytic
and chronic pro-inflammatory state coupled with platelet
hyper-aggregality [3]. Available evidences suggested the
use of dietary intervention as an integral part of future
approaches to prevent and treat obesity and its meta-
bolic consequences [4]. Hence, this study focuses ontd. This is an Open Access article distributed under the terms of the Creative
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consequences of obesity.
Diet-induced metabolic syndrome was found to be the
closest model that at least shares the similar ethologic,
and hence more representative of human pathophysiology
of metabolic syndrome. Human consume high amount fat
and carbohydrate like sucrose and fructose in their diet.
Panchal et al. [5] studied the remodelling effect of high-
carbohydrate high-fat diet-induced obesity in rats using
condensed milk (39.5%), beef tallow (20%), and fructose
(17.5%) with 25% fructose in drinking water and found
that rats developed cardiovascular, metabolic, renal, hep-
atic and pancreatic changes. The complications includes
obesity, increased fat accumulation in abdominal region,
hypertension, insulin resistant, and impaired cardiac
function, endothelial dysfunction as well as inflammation.
Hence, it can be seen that a combination of high carbohy-
drate and high fat diet produce a more human-like model.
This study only utilized male rats to avoid the influence of
the oestrus cycle on food intake which may affect the diet-
induced model [6].
Consumption of fruits and vegetables has long been
linked to the prevention of oxidative stress related dis-
eases like diabetes mellitus, cancer, heart disease, obesity
and micronutrient deficiencies [7-10]. Eating fruits and
vegetables can ensure the adequate supply of micronu-
trients, dietary fibers and phytochemicals which in turn
maintain the body in a healthy state [11]. However, it is
not clear which specific fruits and vegetables are most
protective against certain diseases. Only few studies have
examined the effect of specific fruits or juices on meta-
bolic syndrome risk factors. A large prospective cohort
study for 10.2 years on Swedish men and women found
significantly inverse association of only apples, pears and
green leafy vegetables with stroke [12].
Not all fruits are created equal particularly in terms of
their phytonutrient contents which might influence their
biological properties, and hence their efficacy in relation
to specific diseases. The fruit of Hylocereus polyrhizus,
also known as red pitaya, and buah naga in Malay, is
one of the tropical fruits of the cactus family, Cactaceae.
Polyphenols including flavonoids, betacyanins, vitamin C
and fiber are among the main active constituents in red
pitaya known to confer health benefit [13-15]. However,
betacyanin fractions shown to display the highest reducing
and radical scavenging capacities as compared to poly-
phenolic fractions [16]. Since the study on the physio-
logical effects of red pitaya is still some distance from that
of other fruits, it is interesting to investigate whether
supplementation of 5% red pitaya juice can ameliorate the
metabolic, hepatic and renal function in rats fed a high-
carbohydrate, high-fat diet. To the best of our knowledge,
this is the first study to evaluate the effect of red pitaya
associated with hepatoprotection and cardioprotection.Methods
Preparation of diet
Red pitaya was obtained from Queensland Australia.
The identification of the fruit was done by a botanist from
Biodiversity Unit, Institute of Biosciences, Universiti Putra
Malaysia. The voucher number is SK-2440/14. The fruits
were then cleaned, and the fruit pulp was squeezed
using juice maker. Sample preparation was conducted
in reduced light condition in order to minimize the
pigment loss.
Animals and diet
All experimental protocols were approved by the Animal
Experimentation Ethics Committee of The University of
Southern Queensland under the guidelines of the National
Health and Medical Research Council of Australia. This
study was a randomized control trial. The experimental
groups consisted of 48 male Wistar rats (aged 8–9 weeks;
weight 337 ± 5 g) supplied by and individually housed at
The University of Southern Queensland animal house.
All experimental groups were housed in a temperature-
controlled, 12 hour light–dark cycle environment with ad
libitum access to water and food. Daily body weight, feed
and water measurements were taken to monitor the day-
to-day health of the rats. The rats were randomly divided
into six groups based on their diet: corn starch (C; n = 12);
corn starch + red pitaya juice (CRP; 5% in the diet; n = 12);
high-carbohydrate, high-fat (H; n = 12); High-carbohy-
drate, high-fat + red pitaya juice (HRP; n = 12). Fructose
(25%) was added as drinking water for all high-carbohy-
drate, high-fat fed rats, while corn starch group was given
normal water. The detailed macro- and micro-nutrient
composition of the C and H diets are reported in our pre-
vious publications [17,18]. Red pitaya juice supplementa-
tion was administered for 8 weeks starting from 8 weeks
after the initiation of the C or H diet.
Oral glucose tolerance test
Basal blood glucose concentrations were measured in tail
vein blood using a Medisense Precision Q.I.D glucose
meter (Abbott Laboratories) after overnight (10–12 h)
food deprivation. Fructose-supplemented drinking water
in the H and HRP groups was replaced with normal water
for the overnight food-deprivation period. The rats were
given 2 g/kg body weight of glucose as a 40% solution via
oral gavage. Blood samples from the tail vein were
taken at 0, 30, 60, 90, and 120 minute following glu-
cose administration.
Body composition measurements
Body composition was measured on rats by dual-energy
X-ray absorptiometry (DXA) using a Norland XR36
DXA instrument (Norland, Fort Atkinson, WI, USA)
after 16 weeks of feeding and 2 days before terminal
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facturer’s recommended software for use in laboratory an-
imals (Small Subject Analysis Software, version 2.5.3/1.3.1;
Norland Corp) [19]. The precision error of lean mass for
replicate measurements, with repositioning, was 3.2%. Vis-
ceral adiposity index (%) was calculated as ([retroperi-
toneal fat (g) + omental fat (g) + epididymal fat (g)]/[body
weight (g)]) × 100 and expressed as adiposity percent [17].
Isolated heart preparation
Langendorf heart preparations were used to assess left ven-
tricular function of the rats in all treatment groups. Ter-
minal anaesthesia was induced via intraperitoneal injection
of pentobarbitone sodium (Lethabarb, 100 mg/kg). Hep-
arin (Sigma-Aldrich Australia) was administered (200 IU)
through the right femoral vein and blood (~5 mL) was
drawn out of the abdominal aorta. Isovolumetric ventricu-
lar function was measured by inserting a latex balloon
catheter into the LV connected to a Capto SP844 MLT844
physiological pressure transducer and Chart software
on a Maclab system (ADInstruments Australia and
Pacific Islands). All left ventricular end-diastolic pressure
values were measured while pacing the heart at 250 beats/
min using an electrical stimulator. End-diastolic pressures
were obtained starting from 0 mm Hg up to 30 mm Hg.
The diastolic stiffness constant (k, dimensionless) was
calculated as in previous studies [20]. +dP/dt and −
dP/dt were calculated as the mean rate of contraction
and relaxation, respectively, of at least 50 beats with the
heart paced at 250 beats/min, and the end-diastolic pres-
sure was maintained at approximately 10 mmHg.
Organ weights
The right ventricle and LV were separated after perfusion
experiments and weighed. Liver and abdominal fat were
immediately removed at the time of the heart removals
for perfusion experiments and blotted dry for weigh-
ing. Perirenal, epididymal, and omental fat were together
weighed as abdominal fat. Organ weights were normalized
relative to the tibial length at the time of their removal
(in mg/mm).
Plasma biochemistry analysis
Blood was collected into heparinized tubes and then
centrifuged at 5,000 g for 15 minutes. Plasma samples
were separated and into Eppendorf tubes and stored
at −80°C for analysis. Enzymatic activities and analyte
concentrations in the plasma (AST, ALP, ALT) were
determined using kits and controls supplied by Olympus
using an Olympus analyzer (AU 400). Plasma glucose, uric
acid and urea were estimated using a commercial kit
according to the manufacturer-provided standards and
protocol using a Roche/Hitachi cobas c system.Histology
The liver and heart tissues for 2 rats (n = 2) from each
group were exclusively taken for histopathological ana-
lysis. The samples were immediately fixed in 10% formalin
for 3 days to remove the traces of blood from the tissue.
After that, the samples were dehydrated, embedded in
paraffin wax and then cut into thin sections (5–6 μm). In
order to determine the inflammatory cell infiltration,
the liver and heart tissue sections were stained with
hematoxylin and eosin. Picrosirius red staining was used
to study collagen deposition in left ventricle of the heart
and was analysed using laser confocal microscopy (Zeiss
LSM 510 upright confocal microscope). From each tissue
sample, three slides were prepared and two random, non-
overlapping fields were selected from each slide. A repre-
sentative picture was randomly selected from each group.
Statistical analysis
All data were presented as mean ± SEM. A total of 4
groups were analysed using two-way analysis of variance
(ANOVA). Each group consists of 12 rats. All group data
were tested for variance using Bartlett’s test. Variables
that were not normally distributed were transformed
(using log 10 function) prior to statistical analysis. The
effects of diet, treatment and their interactions were
tested by two-way analysis of variance. When interaction
and/or the main effects were significant, means were
compared using Newman-Keuls multiple-comparison
post hoc test. Where transformations did not result in
normality or constant variance, a Kruskal-Wallis non-
parametric test was performed. P <0.05 was considered
significant. All statistical analyses were performed using
GraphPad Prism version 5.00 for Windows (San Diego,
CA, USA).
Results
Dietary intake
The effects of red pitaya juice on food intake, water
intake and energy intake were determined after 8 weeks of
supplementation. Table 1 shows red pitaya supplementa-
tion significantly increase food intake only in CRP group.
Average food intake for corn starch fed control group (C)
was 36.33 ± 0.9 g/day increased to 40.40 ± 0.7 g/day for
CRP group. On the other hand, no change in food intake
was observed in high-carbohydrate, high-fat diet supple-
mented with red pitaya (27.29 ± 1.3 and 27.74 ± 2.6 g/day
for H and HRP groups, respectively). As shown in Table 1,
red pitaya supplementation did not change water intake in
either group (29.57 ± 2.6, 30.88 ± 1.8, 30.15 ± 1.6, 26.47 ±
2.3, 29.56 ± 5.0 and 21.75 ± 1.1 ml/day for C, CRP, H, and
HRP groups, respectively). Even though food and water
intake were similar in high-carbohydrate, high-fat diet
feeding throughout the study period, rats on this diet sup-
plemented with red pitaya juice had increased in energy
Table 1 Dietary intakes, body composition, organ wet weights and plasma biochemistry analysis in C, CRP, H and HRP
diet-fed rats
Variable C CRP H HRP P-value
Diet Treatment Interaction
Food intake, g/d (n = 7-8) 36.3 ± 0.9b 40.4 ± 0.7a 27.3 ± 1.3c 27.7 ± 2.6c <0.0001 0.0375 0.07
Water intake, ml/d (n = 7-8) 29.6 ± 2.6 30.9 ± 1.7 26.5 ± 2.3 29.6 ± 5.0 0.06 0.3 0.41
Energy intake, kJ/d (n = 8) 405.5 ± 10.2d 512.7 ± 8.3c 569.2 ± 28.7b 655.2 ± 28.7a 0.8041 <0.0001 <0.0001
Body weight gain (8–16 weeks),% (n = 8) 7.1 ± 1.1bc 11.6 ± 2.6b 19.1 ± 1.4a 19.7 ± 1.5a <0.0001 0.12 0.19
Total body fat mass, g (n = 8) 77.5 ± 5.8b 110.6 ± 10.4b 210.8 ± 27.6a 230.4 ± 23.1a <0.0001 0.23 0.85
Total body lean mass, g (n = 8) 296.9 ± 10.6 305.2 ± 3.0 296.8 ± 15.4 286.2 ± 16.0 0.67 0.42 0.31
Abdominal circumference, cm (n = 8) 18.9 ± 0.2d 20.2 ± 0.3c 22.1 ± 0.4b 24.7 ± 0.5a <0.0001 <0.0001 0.0403
Tissue wet weights, mg/mm tibial length (n = 8)
Liver (n = 7-8) 248.8 ± 12.0b 258.0 ± 16.4b 332.5 ± 1.0a 363.2 ± 8.6a <0.0001 0.18 0.41
Kidneys (n = 7-8) 47.92 ± 1.3b 54.62 ± 1.7b 57.31 ± 3.1a 58.62 ± 1.5a 0.0299 0.0856 < 0.0001
Spleen (n = 7-8) 17.27 ± 1.1 19.53 ± 1.2 19.1 ± 0.3 16.11 ± 1.6 0.0042 0.9573 0.1704
Plasma biochemistry analysis
Urea (mmol/L) (n = 7-8) 2.74 ± 0.62 2.94 ± 0.31 2.90 ± 0.33 2.11 ± 0.12 0.1463 0.6032 0.5296
uric acid (μmol/L) (n = 7-8) 32.6 ± 5.36b 45.4 ± 1.37a 26.6 ± 2.2bc 16.4 ± 2.36c 0.0014 0.0793 < 0.0001
Glucose, mmol/L (n = 5-8) 11.2 ± 0.61ab 12.6 ± 1.19a 12.4 ± 0.45ab 9.7 ± 0.44b 0.0118 0.4315 0.6681
Each value is a mean ± S.E.M. Number of repetitive experiments indicated within parenthesis. Means within a row with unlike superscripts letters a, b, c, d differ
significantly (p < 0.05). C, corn starch diet; CRP, corn starch + red pitaya juice; H, high fat diet; HRP, high fat diet + red pitaya juice.
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and HRP) (Table 1).
Body weight
Figure 1 displays body weights of obese rats supplemented
with red pitaya juice. Initially, there was no difference in
body weight for all the treatment groups. After 8 weeks
initiation of the diet, the increased in body weights in
high-carbohydrate, high-fat diet-fed rats were significantly
(p < 0.05) greater than corn starch diet–fed rats. At the0 1 2 3 4 5 6 7 8
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Figure 1 Body weight of obese rats supplemented with red pitaya ju
marked with different letters are significantly different at the level of p < 0.0
diet; HRP, high fat diet + red pitaya juice.end of 8 weeks, supplementation of red pitaya juice failed
to prevent further weight gain compared with C and H
diet-fed rats (Figure 1). Consequently, both supplemented
rats showed the trend of increasing body weight although
the difference was not significant (p < 0.05) (Figure 1).
Plasma biochemistry analysis
The wet weight of the liver and kidneys were signifi-
cantly greater (p < 0.05) in the high carbohydrate, high-
fat diet-fed rats (H) compared with corn starch fed-rats9 10 11 12 13 14 15 16
Red pitaya treatment
ek
bc
b
a
a
ice for 8 weeks. Data are presented as mean ± SEM, n = 5–8. Values
5. C, corn starch diet; CRP, corn starch + red pitaya juice; H, high fat
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significant changes to liver and kidneys wet weight. Con-
trarily, there were no difference in wet weight of the heart
and spleen for all the groups (C, CRP, H and HRP). No
changes in plasma urea concentration in red pitaya sup-
plemented rats compared with C-fed and H-fed rats
(Table 1). Furthermore, red pitaya supplementation showed
the trend of uric acid and glucose normalization for HRP
as compared to H-fed rats (Table 1). Conversely, plasma
uric acid concentration was increased significantly in CRP
rats (p < 0.05) compared with C-fed rats (Table 1).
Glucose tolerance and hepatic function
Red pitaya supplemented groups showed impaired glucose
tolerance even after 8 weeks supplementation (Figure 2).
Overnight fasting blood glucose differs significantly be-
tween H fed rats and C fed rats. Oral administration of
2 g/kg body weight of glucose resulted in increased blood
glucose concentration at 30 minutes and 60 minutes for
C, CRP, H and HRP respectively. Then, blood glucose was
slowly cleared from the blood in H fed rats as observed at
90 minutes. At the end of 120 min, HRP rats failed to
reduce blood glucose concentration to the basal value.
The similar results were observed for CRP rats as com-
pared to C-fed rats (Figure 2). Insulin concentration in all
the rats were unable to be detected using cobas c system0 30 6
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Figure 2 Oral Glucose Tolerance Test (OGTT) at 16 weeks from C, CRP
End-point means without a common alphabet in each data set significantl
juice; H, high fat diet; HRP, high fat diet + red pitaya juice.(data was not shown). High-carbohydrate, high-fat feeding
resulted in elevated levels of plasma alanine transaminase
(ALT), aspartate transaminase (AST) and alkaline phos-
phatase (ALP) as the markers of liver function (Figure 3).
HRP diet feeding decreased the ALP and ALT activities but
significantly increased (p < 0.05) AST activity (Figure 3).
Plasma ALP activity was not affected in CRP group while
plasma ALT was significantly decreased in CRP compared
with C-fed rats (Figure 3). However, plasma AST activity
was decreased in CRP group (p <0.05) (Figure 3).
Cardiovascular function
The measurement of ex-vivo cardiac function of the obese
rats was accomplished by conducting Langendorff isolated
heart. Figure 4 demonstrates that high carbohydrate, high
fat diet-fed rats showed marked increased in diastolic
stiffness in comparison with corn starch diet-fed rats
(Figure 4). Results revealed that diastolic stiffness of the
heart was reduced after supplementation of red pitaya
juice in corn starch fed rats (Figure 4). However, the re-
duction was not significant in HRP rats in comparison
with H rats (Figure 4).
Liver and cardiovascular structure
Histological evaluation of liver tissues showed negligible
fat vacuoles accumulation without inflammatory cells in0 90 120
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Figure 3 Plasma concentrations of liver enzymes of obese rats supplemented with red pitaya juice for 8 weeks. Data are presented as
mean ± SEM, n = 5–8. Values marked with different letters are significantly different at the level of p < 0.05. ALP, alkaline phosphatase; ALT, alanine
transaminase; AST, aspartate transaminase. C, corn starch diet; CRP, corn starch + red pitaya juice; H, high fat diet; HRP, high fat diet + red pitaya juice.
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CRP (Figure 5B) displayed less fat vacuoles accumulation
but demonstrated marked hepatocyte ballooning with
cornered nucleus. High carbohydrate, high fat feeding
for 16 weeks resulted in augmented accumulation of
fat vacuoles in the hepatocytes with sinusoids dilatation
and increased inflammatory cell infiltration in H group
(Figure 5C). Red pitaya supplementation reduces theC CRP
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Figure 4 Diastolic stiffness of obese rats supplemented with red pitay
Values marked with different letters are significantly different at the level o
H, high fat diet; HRP, high fat diet + red pitaya juice.fat vacuoles and infiltration of inflammatory cells
(Figure 5D).
Histological evaluation of left ventricle tissues after fed
with high carbohydrate, high fat diet for 8 weeks resulted
in greater inflammatory cells infiltration (Figure 5G)
compared to CS rats (Figure 5E). Similarly, H rats
showed higher collagen deposition and hypertrophied
cardiomyocytes (Figure 5K) than CS rats (Figure 5I).H HRP
a
ab
a juice for 8 weeks. Data are presented as mean ± SEM, n = 5–8.
f p < 0.05. C, corn starch diet; CRP, corn starch + red pitaya juice;
Figure 5 Histopathology of liver and heart of obese rats supplemented with red pitaya juice for 8 weeks. (A-D) Haematoxylin and eosin
staining of liver section showing hepatocytes with enlarged fat vacuoles (marked as “fv”) (× 20), sinusoids dilatation (marked as “sd”) and
inflammatory cells infiltration around the sinusoids (marked as “in”) (× 20). (E-H) Hematoxylin and eosin staining of left ventricle showing
inflammatory cell infiltration (× 20) (marked as “in”) as dark spots outside the myocytes. (I-L) Picrosirius red staining of left ventricle showing
interstitial collagen deposition (× 20) (marked as “cd”) and hypertrophied cardiomyocytes (marked as “hy”). A,E,I, corn starch diet; B,F,J, corn
starch + red pitaya juice; C,G,K, high fat diet; D,H,L, high fat diet + red pitaya juice.
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rats showed slightly greater infiltration by inflammatory
cells into the left ventricle (Figure 5H). However, HRP rats
showed reduced collagen deposition (Figure 5L). On the
other hand, no changes in inflammatory cell infiltration
were observed in CRP rats (Figure 5F) while collagen de-
position was greater in CRP rats (Figure 5J) compared to
CS rats (Figure 5I).
Discussion
In this study, red pitaya juice was used as an intervention
in order to investigate the ability of the fruit juice to re-
verse the abnormalities in body composition, metabolic,
liver, kidneys and heart function in high carbohydrate,
high-fat diet induced obese rats as a model of metabolic
syndrome. Previous research confirmed that rats fed with
high carbohydrate and high fat diet for 8 weeks produced
abdominal obesity, impaired glucose tolerance, hyperten-
sion, dyslipidemia, inflammation, endothelial dysfunction,
cardiac fibrosis together with increased stiffness of the
heart [17,18]. All these changes closely mimic the human
metabolic syndrome.
Results revealed that red pitaya supplementation in-
creased food intake only in corn starch diet-fed control
rats while no changes were observed in red pitaya juicesupplementation for high carbohydrate, high-fat diet-
induced obese rats and the corn starch diet fed control
rats. In other words, the intervention does not affect sati-
ety of obese rats as the quantity of food taken was shown
to be regulated by the factors involved in satiety percep-
tion [21]. There was report suggesting that the food intake
was influenced by the sensitivity of the rats to the palat-
ability of the food in the diet [22]. Therefore, it was pro-
posed that the lean control rats in the present study were
more sensitive to the palatability of red pitaya juice as
compared to high carbohydrate, high-fat diet-induced
obese rats. Food rich in sugar and fat is an example of
palatable foods that inhibit the satiety signals and up regu-
late hunger sensation [23]. Despite of that, energy intake
was increased significantly for red pitaya supplemented
rats suggested that red pitaya contains higher amount of
energy-supplying macronutrients. Red pitaya added up to
the total energy content of the diet, leading to progressive
increment in body weight, and total body fat through-
out the intervention period. A growing body evidences
showed that eating fruits can reduce energy density and
reduce energy density is associated with lower energy in-
take and decrease body weight [24]. Furthermore, Flood-
Obbagy and Rolls [25] indicated that consumption of
fruits before meal can increase satiety and reduce energy
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fruits. Whole fruit is related to more chewing while fruit
juices do not require chewing at all. The amount of chew-
ing is then linked to cephalic-phase responses that control
the food intake [26,27]. This may explain the reduce risk
of type 2 diabetes mellitus following consumption of
specific whole fruits particularly grapes, apples, bananas,
and blueberries in prospective longitudinal cohort study
among women and men from Nurses’ Health study and
Health Professionals Health Study respectively [28].
It is fascinating to address the suppression effects of
red pitaya on body fat for HRP rats. As the diet was
continue for 8 weeks, supplementation of red pitaya
did not result in further weight gain for obese rats. A
current review on regulation of body fat mass in obesity
indicated that body resisted fat loss once obesity is
established [21] probably through adaptive mechanism
of increasing metabolic rate. Contradictory, total body
fat mass in corn starch fed rats were significantly elevated
when supplemented with red pitaya. It could be the nor-
mal physiological responses upon increasing energy intake
in red pitaya supplemented rats. In conjunction with that
abdominal circumference were increased in CRP and HRP
rats. A possible explanation for this might be that the
increase in fat mass in red pitaya fed rats was deposited in
abdominal region, hence it can be detrimental to their
health. It was expected to see no changes in lean mass for
red pitaya supplemented rats as lean mass is a metabo-
lically active tissues required for maintaining basic cell
function, thus was not affected by treatment.
Liver and kidneys from H fed rats had higher wet
weights as compared to C fed rats as observed in previous
study [17] while no changes in wet weight of spleen and
hearts. Likewise, a recent study presented liver abnormal-
ities comprises of higher liver weight, increases in alanine
transaminase (ALT) and aspartate transaminase (AST) and
the occurrence of inflammatory infiltrates in rats while
renal abnormalities were evidenced from the increased in
weight, fat accumulation, and glomerular sclerosis with
consumption of high fat diet [29]. A probably explanation
for this defects is through the deposition of lipid in the
liver upon fructose exposure which in turn conquer most
of the hepatocytes volume and upset the liver structure
and function [30]. Besides, some glucose transporter
like GLUT2 may be involved in the transport of fruc-
tose to the kidney [31]. Besides, red pitaya-fed rats
showed a trend of reduction in stiffness of the heart.
Previous studies reported that diastolic stiffness, car-
diac fibrosis, and elevated superoxide production were
directly associated with each other [18]. Therefore, it
could be that the accumulation of interstitial cardiac
collagen was reduced [32] following red pitaya supple-
mentation, hence showed the trend of ameliorating
cardiac stiffness.To have better insight of liver function, the enzymes
activities were measured. The collective measurement of
alkaline phosphatase (ALP), alanine transaminase (ALT)
and aspartate transaminase (AST) reflects the severity of
liver damage. ALP is induction enzyme that is mainly
found in the cell membrane of the liver and the eleva-
tion of this enzyme indicates primary hepatic disease like
cholestatic liver disease. Although the increase in ALP
can be result from extra-hepatic sources like bone marrow
and skeletal muscle, the effects was minimal. Whilst, both
ALT and AST are leakage enzymes, and their elevation
indicate significant hepatocellular damage. The possible
causes may vary including toxicity, inflammation, hypoxia
and tissue trauma [33]. However, AST is also found in
heart, kidneys, brain, and skeletal muscle and had been
used as a nonspecific marker for myocardiac infarction
[34]. Results revealed that red pitaya juice treatment sig-
nificantly reduced ALP and ALT but caused significant
increment in AST. Therefore, the present results suggest
that red pitaya juice ameliorated liver damage due to high
carbohydrate, high fat feeding. The reduction of liver
enzymes after the intervention probably indicated the
decrease in deposition of fat and the degree of necrosis in
liver cells [35]. In contrast, the elevated level of AST could
be due to myocardial damage as the heart muscle is rich
in aminotransferase enzymes especially AST. The de-
crease in ALT has been shown to have protective effects
from death diabetes and Ischemic heart disease in adults
from National Health and Nutrition Examination Survey
(NHANES) III [36]. On the other hand, the increased in
ALT has been associated with systemic and hepatic insulin
resistance, along with increase in the secretion of insulin
and reduces insulin clearance from the liver [37]. Hence,
the present study showed that red pitaya juice is an
important mediator for attenuation of liver injury. His-
topathological evidence of liver and heart section after
supplementation with 5% red pitaya juice revealed mild
improvement in hepatic vacuolation and no inflammation
was seen during microscopic examination. Also, the colla-
gen deposition was reduced in left ventricle of the heart.
This results was in line with the reduce ALP and ALT
enzymes indicative of improvement in liver injury as well
as consistent with a slightly reduction in diastolic stiffness.
Previous report indicated that intervention with 5% purple
carrot juice was also able to reverse the structural damage
in the liver caused by high fat feeding by showing minimal
signs of microvesicular steatosis [18].
Conclusion
In summary, the present data provide scientific evi-
dences that red pitaya juice may provide protection
against liver damage and may reduce the stiffness of the
heart. Red pitaya juice contained multiple bioactive com-
pounds which might act synergistically to produce the
Ramli et al. BMC Complementary and Alternative Medicine 2014, 14:189 Page 9 of 10
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stituents are not investigated in the present study. There-
fore, it is suggested to conduct future study in order to
elucidate the possible active compounds responsible for
the effects. Besides, further study with higher doses of red
pitaya in diet-induced obesity model can be conducted in
future to examine the ability of this fruit for the treatment
of obesity related diseases. It is also crucial to take into
consideration the timing of fruit juice consumption. This
is because eating fruit before meals may reduce energy
intake by means of increasing fiber intake. The therapeutic
effects of specific fruits should be investigated rather
giving general recommendation to the general population.
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